Lv62
1710 积分 2025-10-18 加入
PCSK9-directed therapies: an update
11天前
已完结
New Oral PCSK9 Inhibitor: "MK-0616"
11天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
11天前
已完结
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
11天前
已完结
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
13天前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
13天前
已完结
HighMPNN: A Graph Neural Network Approach for Structure-Constrained Cyclic Peptide Sequence Design
17天前
已完结
Cyclized Helical Peptides: Synthesis, Properties, and Therapeutic Applications
17天前
已完结
Peptide and Protein Design for Biopharmaceutical Applications
17天前
已完结
Protein Physics: A Course of Lectures
17天前
已完结
皖公网安备34019202002308
